Table 4.
Univariate Regression Analysis | p Value | OR | (95% CI of OR) |
Age ≤ 50 years | 0.005 | 33.000 | 2.909–374.311 |
Female sex | 0.682 | 1.400 | 0.279–7.016 |
Right-sided tumor localization | 0.045 | 7.000 | 1.044–46.949 |
TNM stage of the disease (III) | 0.674 | 0.700 | 0.133–3.684 |
Metastases in regional lymph nodes (present) | 0.674 | 0.700 | 0.133–3.684 |
Mucinous adenocarcinoma | 0.096 | 0.200 | 0.030–1.329 |
High-grade tumor | 0.617 | 0.600 | 0.081–4.447 |
Presence of mucinous secretion | 0.682 | 1.400 | 0.279–7.016 |
Expressed peritumoral lymphocyte infiltration | 1.000 | 1.000 | 0.183–5.460 |
Crohn-like reaction (positive) | 0.020 | 10.000 | 1.444–69.262 |
High-grade tumor budding | 0.005 | 33.000 | 2.909–374.311 |
Lymphovascular invasion (present) | 0.353 | 0.400 | 0.058–2.770 |
Perineural spread (present) | 1.000 | 1.000 | 0.202–4.955 |
Multivariate Regression Analysis | p Value | OR | (95% CI of OR) |
Age ≤ 50 years | 0.997 | 9.863 × 1015 | 0.000–∞ |
Right-sided tumor localization | 0.997 | 6.014 × 1015 | 0.000–∞ |
Crohn-like reaction (positive) | 0.998 | 120,003,272.9 | 0.000–∞ |
High-grade tumor budding | 0.997 | 196,797,989.8 | 0.000–∞ |
Odds ratio, OR; confidence interval, CI.